These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24287754)

  • 21. Evaluation of socio-economic factors causing discontinuation of epilepsy treatment resulting in seizure recurrence: a study in an urban epilepsy clinic in India.
    Das K; Banerjee M; Mondal GP; Devi LG; Singh OP; Mukherjee BB
    Seizure; 2007 Oct; 16(7):601-7. PubMed ID: 17576079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of focal epilepsy in adults treated with polytherapy in France: the direct cost of drug resistance (ESPERA study).
    de Zélicourt M; de Toffol B; Vespignani H; Laurendeau C; Lévy-Bachelot L; Murat C; Fagnani F
    Seizure; 2014 May; 23(5):349-56. PubMed ID: 24560531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of diagnosis and therapeutic care of epilepsy at a tertiary referral center in Nigeria.
    Igwe SC; Brigo F; Beida O
    Epilepsia; 2014 Mar; 55(3):442-7. PubMed ID: 24502448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
    Davis KL; Candrilli SD; Edin HM
    Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Economic aspects of drug-resistant epilepsy].
    Owczarek K; Jedrzejczak J
    Neurol Neurochir Pol; 2001; 35(2):309-18. PubMed ID: 11599228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The direct medical costs of epilepsy in children and young people: a population-based study of health resource utilisation.
    Ali MA; Elliott RA; Tata LJ
    Epilepsy Res; 2014 Mar; 108(3):576-86. PubMed ID: 24447611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of direct, indirect, and intangible costs of epilepsy.
    Pato Pato A; Cebrián Pérez E; Cimas Hernando I; Lorenzo González JR; Rodríguez Constenla I; Gude Sampedro F
    Neurologia; 2011; 26(1):32-8. PubMed ID: 21163205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study.
    Nsengiyumva G; Druet-Cabanac M; Nzisabira L; Preux PM; Vergnenègre A
    Epilepsia; 2004 Jun; 45(6):673-7. PubMed ID: 15144433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of drug resistant epilepsy in adults with epilepsy attending a neurology clinic of a tertiary referral hospital in Singapore.
    Kong ST; Ho CS; Ho PC; Lim SH
    Epilepsy Res; 2014 Sep; 108(7):1253-62. PubMed ID: 24910376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
    Argumosa A; Herranz JL
    Rev Neurol; 2005 Jul 1-15; 41(1):45-9. PubMed ID: 15999330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-term retrospective matched cohort study.
    Borghs S; Thieffry S; Noack-Rink M; Dedeken P; Hong LS; Byram L; Logan J; Chan J; Kiri V
    BMC Neurol; 2017 Mar; 17(1):59. PubMed ID: 28335764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
    Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
    Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annual direct medical cost and contributing factors to total cost of epilepsy in Oman.
    Al-Zakwani I; Hanssens Y; Deleu D; Cohen A; McGhan W; Al-Balushi K; Al-Hashar A
    Seizure; 2003 Dec; 12(8):555-60. PubMed ID: 14630493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries.
    Paradis PE; Latrémouille-Viau D; Moore Y; Mishagina N; Lafeuille MH; Lefebvre P; Gaudig M; Duh MS
    Curr Med Res Opin; 2009 Jul; 25(7):1793-805. PubMed ID: 19505202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis.
    Chisholm D;
    Epilepsia; 2005 May; 46(5):751-9. PubMed ID: 15857443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy.
    Ettinger AB; Manjunath R; Candrilli SD; Davis KL
    Epilepsy Behav; 2009 Feb; 14(2):324-9. PubMed ID: 19028602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct medical costs for partial refractory epilepsy in Mexico.
    García-Contreras F; Constantino-Casas P; Castro-Ríos A; Nevárez-Sida A; Estrada Correa Gdel C; Carlos Rivera F; Guzmán-Caniupan J; Torres-Arreola Ldel P; Contreras-Hernández I; Mould-Quevedo J; Garduño-Espinosa J
    Arch Med Res; 2006 Apr; 37(3):376-83. PubMed ID: 16513488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy.
    Luoni C; Canevini MP; Capovilla G; De Sarro G; Galimberti CA; Gatti G; Guerrini R; La Neve A; Mazzucchelli I; Rosati E; Specchio LM; Striano S; Tinuper P; Perucca E
    Epilepsia; 2015 Jul; 56(7):1162-73. PubMed ID: 26046371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic differences in direct and indirect costs between people with epilepsy and without epilepsy.
    Libby AM; Ghushchyan V; McQueen RB; Slejko JF; Bainbridge JL; Campbell JD
    Med Care; 2012 Nov; 50(11):928-33. PubMed ID: 23047781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization.
    Manjunath R; Paradis PE; Parisé H; Lafeuille MH; Bowers B; Duh MS; Lefebvre P; Faught E
    Neurology; 2012 Oct; 79(18):1908-16. PubMed ID: 23077014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.